Theoretically, in view of the decrease in the number of lymphocytes and their subsets in the early stage of the disease (24, 25) and the poor immune function potentially caused by various complications (26, 27), ALB and PAB are potential and feasible predictors for the prognosis of COVID-19. The gene discussed is ALB; the disease is COVID-19.